VAGAGGINI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 1.691
AS - Asia 1.468
NA - Nord America 1.246
SA - Sud America 256
AF - Africa 68
OC - Oceania 7
Totale 4.736
Nazione #
US - Stati Uniti d'America 1.170
IT - Italia 547
RU - Federazione Russa 547
SG - Singapore 490
CN - Cina 378
BR - Brasile 211
VN - Vietnam 190
IE - Irlanda 123
KR - Corea 112
HK - Hong Kong 97
DE - Germania 92
FR - Francia 77
GB - Regno Unito 66
IN - India 58
BD - Bangladesh 49
FI - Finlandia 43
ZA - Sudafrica 35
NL - Olanda 33
MX - Messico 32
CA - Canada 25
PL - Polonia 25
ES - Italia 24
SE - Svezia 23
AT - Austria 14
CZ - Repubblica Ceca 14
JP - Giappone 14
KE - Kenya 14
AR - Argentina 12
IQ - Iraq 10
EC - Ecuador 9
GR - Grecia 9
UA - Ucraina 9
IR - Iran 8
PK - Pakistan 8
AU - Australia 7
JM - Giamaica 7
PT - Portogallo 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
ID - Indonesia 6
MA - Marocco 6
LI - Liechtenstein 5
PY - Paraguay 5
VE - Venezuela 5
CH - Svizzera 4
CO - Colombia 4
PH - Filippine 4
SA - Arabia Saudita 4
TN - Tunisia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
AM - Armenia 2
CR - Costa Rica 2
DK - Danimarca 2
KG - Kirghizistan 2
LV - Lettonia 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
TT - Trinidad e Tobago 1
Totale 4.736
Città #
Singapore 316
Dallas 211
Hefei 165
Moscow 159
San Jose 145
Dublin 122
Siena 120
Seoul 109
Santa Clara 107
Ashburn 101
Hong Kong 93
Milan 93
Beijing 70
Florence 62
Ho Chi Minh City 60
New York 60
Council Bluffs 52
Los Angeles 51
Lauterbourg 41
Hanoi 39
The Dalles 34
Johannesburg 31
Munich 31
São Paulo 28
Bengaluru 26
Lappeenranta 25
Rome 23
Buffalo 20
Chicago 20
Orem 19
Frankfurt am Main 17
Amsterdam 15
Warsaw 15
Da Nang 14
Nuremberg 14
Mexico City 12
Montreal 12
Portsmouth 12
Tokyo 12
Helsinki 11
London 11
Stockholm 11
Belo Horizonte 10
Naples 10
Redondo Beach 10
Salt Lake City 10
Boardman 9
Brno 9
Chandler 9
Düsseldorf 9
Haiphong 9
Poplar 9
Turin 9
Vienna 9
Bologna 8
Brescia 8
Paris 8
Shanghai 8
Toronto 8
Brasília 7
Brooklyn 7
Calci 7
Dhaka 7
Guayaquil 7
Hải Dương 7
Manchester 7
New Delhi 7
Querétaro 7
Rio de Janeiro 7
Kingston 6
Lisbon 6
Piscataway 6
Atlanta 5
Boston 5
Chennai 5
Columbus 5
Guangzhou 5
L’Aquila 5
Oxford 5
Santo André 5
Ankara 4
Barnet 4
Caldes de Montbui 4
Denver 4
Duhok 4
Jacksonville 4
Leipzig 4
Mumbai 4
Nairobi 4
Newark 4
Pune 4
Sydney 4
Tashkent 4
Tehran 4
Thessaloniki 4
Tunis 4
Turku 4
Venda Nova do Imigrante 4
Aversa 3
Baghdad 3
Totale 2.947
Nome #
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth 257
A Facile Access to Green Fluorescent Albumin Derivatives 229
Characterization of in vitro and in vivo properties of pharmacologically active compounds in a GLP-Like laboratory 201
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents 201
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 193
Serendipitous identification of azine anticancer agents using a privileged scaffold morphing strategy 183
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 182
A greener technique for microwave-assisted O-Silylation and silyl ether deprotection of uridine and other substrates 174
DEAD-Box Helicase DDX3X as a host target against emerging viruses: new insights for medicinal chemical approaches 169
Development and validation of derivatization-based LC-MS/MS method for quantification of short-chain fatty acids in human, rat, and mouse plasma 165
Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model 165
Efficient use of agricultural waste to naturally fortify Tenebrio molitor mealworms and evaluation of their nutraceutical properties 165
Exploiting fall foliage by-products to optimize Tenebrio molitor nutraceutical value 163
Reversible monoacylglycerol lipase inhibitors: discovery of a new class of benzylpiperidine derivatives 157
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinoma 148
Progress towards adjuvant development: focus on antiviral therapy 148
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors 146
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme 146
Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders 143
The replacement of flour-based feed with pellets reduces dustiness and improves tenebrio molitor breeders' safety 131
Sweet cherry extract as permeation enhancer of tyrosine kinase inhibitors: a promising prospective for future oral anticancer therapies 128
Proteins from Tenebrio molitor: an interesting functional ingredient and a source of ACE inhibitory peptides 127
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity 125
Infesting Seaweeds as a Novel Functional Food: Analysis of Nutrients, Antioxidants and ACE Inhibitory Effects 125
Use of distillery by-products as Tenebrio molitor mealworm feed supplement 123
Upcycling Milk Industry Byproducts into Tenebrio molitor Larvae: Investigation on Fat, Protein, and Sugar Composition 117
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 116
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 105
Exploitation of the Nutraceutical Potential of the Infesting Seaweed Chaetomorpha linum as a Yellow Mealworms’ Feed: Focus on Nutrients and Antioxidant Activity 103
Triazolo[3,4- b]benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes 93
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment 49
Insects as Source of Nutraceuticals with Antioxidant, Antihypertensive, and Antidiabetic Properties: Focus on the Species Approved in Europe up to 2024 49
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration 48
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents 36
Evaluation of anti-tumoral activity in 3D cell model of a Src inhibitor prodrug for glioblastoma treatment 34
Optimization of 2,3-dihydrophthalazine-1,4-dione PARP inhibitor scaffold for nanomolar potency and specificity towards human PARP10 23
From Ecological Threat to Bioactive Resource: The Nutraceutical Components of Blue Crab (Callinectes sapidus) 12
Totale 4.879
Categoria #
all - tutte 12.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 0 0 0 4 5
2022/2023103 1 6 5 6 5 31 4 17 11 7 3 7
2023/2024386 11 13 11 25 11 53 74 17 11 23 44 93
2024/20251.307 48 30 116 101 141 65 96 98 101 74 120 317
2025/20263.074 212 383 267 406 620 133 381 108 156 229 176 3
Totale 4.879